- Investing Ideas
- Danish Pharmaceuticals & Biotech High Insider Buying
Danish Pharmaceuticals & Biotech High Insider Buying
Results
3
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
3 companies
H. Lundbeck
Market Cap: DKK 37.2b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 37.68
7D
-2.7%
1Y
-4.2%
ChemoMetec
Market Cap: DKK 7.3b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 412.80
7D
-1.8%
1Y
-25.6%
Gubra
Market Cap: DKK 6.5b
A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.
GUBRA
DKK 380.60
7D
-2.7%
1Y
-25.7%